India’s pharma billionaire eyes world’s top insulin supplier crown
The company sees opportunity in a market increasingly overlooked by major pharmaceutical groups.
Auto Added by WPeMatico
The company sees opportunity in a market increasingly overlooked by major pharmaceutical groups.